Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cytodiagnosis | 3 | 2021 | 447 | 1.100 |
Why?
|
Bile Duct Neoplasms | 3 | 2021 | 605 | 0.990 |
Why?
|
Laboratories, Hospital | 1 | 2021 | 192 | 0.670 |
Why?
|
Bile Ducts | 1 | 2020 | 282 | 0.640 |
Why?
|
Adenocarcinoma | 5 | 2021 | 6346 | 0.640 |
Why?
|
Immunochemistry | 1 | 2018 | 116 | 0.630 |
Why?
|
Chemistry, Clinical | 1 | 2018 | 64 | 0.600 |
Why?
|
Homocystinuria | 1 | 2018 | 64 | 0.590 |
Why?
|
Ring Chromosomes | 1 | 2017 | 26 | 0.590 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2018 | 117 | 0.570 |
Why?
|
Blood Specimen Collection | 1 | 2018 | 238 | 0.570 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2018 | 110 | 0.550 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2021 | 3639 | 0.540 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2017 | 120 | 0.540 |
Why?
|
Cystadenoma, Mucinous | 1 | 2016 | 62 | 0.540 |
Why?
|
Pancreatic Cyst | 2 | 2018 | 367 | 0.530 |
Why?
|
Cholangiocarcinoma | 2 | 2021 | 552 | 0.510 |
Why?
|
Quality Control | 1 | 2018 | 832 | 0.500 |
Why?
|
Chromosomes, Human | 1 | 2017 | 441 | 0.500 |
Why?
|
Homocysteine | 1 | 2018 | 638 | 0.480 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2017 | 194 | 0.470 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 787 | 0.470 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2021 | 954 | 0.450 |
Why?
|
Microsatellite Instability | 1 | 2016 | 716 | 0.410 |
Why?
|
Esophageal Neoplasms | 1 | 2021 | 1654 | 0.350 |
Why?
|
Stomach Neoplasms | 1 | 2021 | 1459 | 0.350 |
Why?
|
Pancreatic Neoplasms | 5 | 2021 | 5369 | 0.350 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1092 | 0.350 |
Why?
|
Medical Errors | 1 | 2018 | 1263 | 0.350 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2017 | 946 | 0.350 |
Why?
|
Carcinoma | 1 | 2021 | 2330 | 0.350 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2016 | 1784 | 0.320 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2759 | 0.290 |
Why?
|
Myelodysplastic Syndromes | 1 | 2017 | 1394 | 0.280 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2057 | 0.260 |
Why?
|
Adenoma | 1 | 2017 | 2160 | 0.260 |
Why?
|
Seizures | 1 | 2018 | 2957 | 0.240 |
Why?
|
Thyroid Neoplasms | 1 | 2018 | 2332 | 0.230 |
Why?
|
Kaplan-Meier Estimate | 3 | 2018 | 6484 | 0.200 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2017 | 3615 | 0.190 |
Why?
|
Neuroendocrine Tumors | 2 | 2018 | 641 | 0.190 |
Why?
|
Cell Biology | 1 | 2021 | 90 | 0.180 |
Why?
|
Genes, p16 | 1 | 2020 | 160 | 0.170 |
Why?
|
Pathology, Surgical | 1 | 2021 | 151 | 0.170 |
Why?
|
Cholangitis, Sclerosing | 1 | 2021 | 177 | 0.170 |
Why?
|
Cytological Techniques | 1 | 2021 | 218 | 0.160 |
Why?
|
Smad4 Protein | 1 | 2020 | 191 | 0.160 |
Why?
|
Pathology | 1 | 2021 | 270 | 0.150 |
Why?
|
Protein S Deficiency | 1 | 2017 | 13 | 0.150 |
Why?
|
Activated Protein C Resistance | 1 | 2017 | 18 | 0.150 |
Why?
|
Algorithms | 1 | 2018 | 14032 | 0.150 |
Why?
|
Genes, p53 | 1 | 2020 | 712 | 0.150 |
Why?
|
Reference Standards | 1 | 2021 | 1003 | 0.140 |
Why?
|
Disease-Free Survival | 2 | 2018 | 6815 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 698 | 0.140 |
Why?
|
Factor V | 1 | 2017 | 167 | 0.140 |
Why?
|
Biliary Tract Neoplasms | 1 | 2019 | 185 | 0.140 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2017 | 62 | 0.140 |
Why?
|
Cystadenoma, Serous | 1 | 2017 | 100 | 0.130 |
Why?
|
Epidermal Cyst | 1 | 2017 | 64 | 0.130 |
Why?
|
Splenic Diseases | 1 | 2017 | 90 | 0.130 |
Why?
|
Ampulla of Vater | 1 | 2017 | 149 | 0.130 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6935 | 0.130 |
Why?
|
Cyst Fluid | 1 | 2016 | 83 | 0.130 |
Why?
|
Incidental Findings | 1 | 2021 | 697 | 0.130 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2017 | 1728 | 0.130 |
Why?
|
Marfan Syndrome | 1 | 2018 | 236 | 0.130 |
Why?
|
Karyotyping | 1 | 2017 | 1171 | 0.130 |
Why?
|
Immunohistochemistry | 2 | 2021 | 11076 | 0.130 |
Why?
|
Patient Care | 1 | 2021 | 622 | 0.120 |
Why?
|
Carcinoembryonic Antigen | 1 | 2016 | 337 | 0.120 |
Why?
|
Interdisciplinary Communication | 1 | 2021 | 931 | 0.120 |
Why?
|
New York City | 1 | 2017 | 731 | 0.120 |
Why?
|
Pancreatic Diseases | 1 | 2017 | 343 | 0.120 |
Why?
|
Pancreas | 2 | 2021 | 1691 | 0.120 |
Why?
|
Laboratories | 1 | 2018 | 458 | 0.120 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2018 | 517 | 0.120 |
Why?
|
Preoperative Period | 1 | 2016 | 551 | 0.110 |
Why?
|
Pancreatitis, Chronic | 1 | 2017 | 289 | 0.110 |
Why?
|
Terminology as Topic | 1 | 2021 | 1530 | 0.110 |
Why?
|
Brain Edema | 1 | 2018 | 604 | 0.110 |
Why?
|
Tumor Escape | 1 | 2016 | 370 | 0.110 |
Why?
|
Genomic Instability | 1 | 2017 | 709 | 0.110 |
Why?
|
Humans | 19 | 2021 | 761572 | 0.100 |
Why?
|
Societies, Medical | 2 | 2021 | 3905 | 0.100 |
Why?
|
Aged, 80 and over | 7 | 2019 | 58986 | 0.100 |
Why?
|
Biopsy | 2 | 2021 | 6766 | 0.100 |
Why?
|
Cell Nucleus | 1 | 2020 | 2910 | 0.090 |
Why?
|
Brain | 1 | 2018 | 27120 | 0.090 |
Why?
|
Tumor Burden | 1 | 2016 | 1893 | 0.090 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3416 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2020 | 2917 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2811 | 0.080 |
Why?
|
Mutation | 3 | 2020 | 30054 | 0.080 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2014 | 822 | 0.080 |
Why?
|
Education, Medical, Graduate | 1 | 2021 | 2373 | 0.080 |
Why?
|
Prognosis | 2 | 2021 | 29629 | 0.080 |
Why?
|
Chromatin | 1 | 2020 | 2961 | 0.080 |
Why?
|
Aged | 8 | 2019 | 169310 | 0.070 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4111 | 0.070 |
Why?
|
Interferon-gamma | 1 | 2014 | 3162 | 0.070 |
Why?
|
Adult | 8 | 2019 | 221203 | 0.060 |
Why?
|
Quality Improvement | 1 | 2021 | 3801 | 0.060 |
Why?
|
Male | 10 | 2019 | 360842 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14666 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9326 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3617 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14607 | 0.060 |
Why?
|
Odds Ratio | 1 | 2016 | 9646 | 0.060 |
Why?
|
Young Adult | 4 | 2018 | 59255 | 0.060 |
Why?
|
Tumor Microenvironment | 1 | 2016 | 3877 | 0.050 |
Why?
|
Middle Aged | 7 | 2019 | 220920 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12059 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12975 | 0.050 |
Why?
|
Female | 9 | 2019 | 392686 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39107 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12463 | 0.050 |
Why?
|
Logistic Models | 1 | 2016 | 13255 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11121 | 0.050 |
Why?
|
Disease Progression | 1 | 2017 | 13510 | 0.040 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2021 | 296 | 0.040 |
Why?
|
Phenotype | 1 | 2017 | 16592 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 22176 | 0.040 |
Why?
|
Adolescent | 2 | 2018 | 88324 | 0.040 |
Why?
|
Protein S | 1 | 2017 | 30 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2021 | 1096 | 0.040 |
Why?
|
Certification | 1 | 2021 | 418 | 0.040 |
Why?
|
False Negative Reactions | 1 | 2017 | 573 | 0.030 |
Why?
|
Blood Coagulation Tests | 1 | 2017 | 271 | 0.030 |
Why?
|
Specialization | 1 | 2021 | 778 | 0.030 |
Why?
|
Time Factors | 1 | 2017 | 39970 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17904 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2021 | 2510 | 0.030 |
Why?
|
World Health Organization | 1 | 2021 | 1322 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20571 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2017 | 2016 | 0.030 |
Why?
|
Rats, Inbred Lew | 1 | 2014 | 1157 | 0.030 |
Why?
|
Macaca fascicularis | 1 | 2014 | 903 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2017 | 1229 | 0.020 |
Why?
|
Heterozygote | 1 | 2017 | 2787 | 0.020 |
Why?
|
Prospective Studies | 3 | 2021 | 54426 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36429 | 0.020 |
Why?
|
United States | 1 | 2018 | 72335 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 2915 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2017 | 2385 | 0.020 |
Why?
|
Risk Factors | 1 | 2016 | 74213 | 0.020 |
Why?
|
Curriculum | 1 | 2021 | 3743 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2017 | 3466 | 0.020 |
Why?
|
Clinical Competence | 1 | 2021 | 4793 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 10090 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2014 | 4544 | 0.010 |
Why?
|
Rats | 1 | 2014 | 23741 | 0.010 |
Why?
|
Animals | 2 | 2017 | 168467 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 80646 | 0.010 |
Why?
|
Mice | 1 | 2017 | 81533 | 0.010 |
Why?
|
Concepts
(155)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_